MedTrace Logo

Hybrid AF -- A Prospective Registry

NCT01636518 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-04-22

No results posted yet for this study

Summary

Atrial Fibrillation (AF) is a form of rapid irregular heart rhythm that starts in the upper chambers of the heart (called atria) and is often associated with many health problems. It can cause stroke, palpitations and heart failure. The management of long standing (chronic) AF may require additional medications and blood thinners, potentially for life. It may also require procedures where the heart is shocked with an electrical current to restore normal rhythm. Some patients require a procedure called radiofrequency ablation to address the arrhythmia.

The purpose of this registry is to collect information on patients undergoing this combination of procedures into a database, and to then use this information for scientific study to improve the treatment of atrial fibrillation.

Conditions

Interventions

PROCEDURE

Standard of Care

Standard of care procedure as determined by treating physician for Atrial Fibrillation

Sponsors & Collaborators

  • Estech

    collaborator OTHER

  • Dhanunjaya Lakkireddy, MD, FACC

    lead OTHER

Principal Investigators

  • Dhanunjaya Lakkireddy, MD, FACC · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-01-31
Completion
2015-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01636518 on ClinicalTrials.gov